- Home
- TCBX vs PRME Comparison
TCBX vs PRME Comparison
Compare TCBX & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TCBX | PRME |
|---|---|---|
| Founded | 2008 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Banks | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 716.7M | 666.1M |
| IPO Year | 2021 | 2022 |
Fundamental Metrics
Financial Performance| Metric | TCBX | PRME |
|---|---|---|
| Price | $41.87 | $3.28 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 5 |
| Target Price | ★ $42.33 | $6.42 |
| AVG Volume (30 Days) | 63.2K | ★ 2.3M |
| Earning Date | 04-21-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 40.40 | 24.31 |
| EPS | ★ 2.77 | N/A |
| Revenue | N/A | ★ $2,983,000.00 |
| Revenue This Year | $29.99 | $95.64 |
| Revenue Next Year | $10.14 | N/A |
| P/E Ratio | $15.03 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $25.17 | $1.11 |
| 52 Week High | $43.84 | $6.94 |
Technical Indicators
Market Signals| Indicator | TCBX | PRME |
|---|---|---|
| Relative Strength Index (RSI) | 57.15 | 38.39 |
| Support Level | $40.50 | $3.18 |
| Resistance Level | $43.50 | $3.39 |
| Average True Range (ATR) | 1.31 | 0.25 |
| MACD | -0.10 | -0.04 |
| Stochastic Oscillator | 59.58 | 8.52 |
Price Performance
Historical ComparisonAbout TCBX Third Coast Bancshares Inc.
Third Coast Bancshares Inc is a bank holding company. It focuses on providing commercial banking solutions to small and medium-sized businesses and professionals with operations in its markets. The bank operates eleven branches in the Greater Houston, Dallas-Fort Worth, and Austin-San Antonio markets, and one branch in Detroit, Texas. The company operates through one segment, community banking, It generates the majority of its revenue from interest on loans, customer service, and loan fees.
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.